肺または呼吸器ドラッグデリバリーの世界市場レポート 2025年

肺または呼吸器ドラッグデリバリー市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.0％で1,078億5,000万米ドルに成長します。予測期間中は、個別化医療に対する需要の高まり、慢性呼吸器疾患の蔓延、遠隔医療への注目の高まり、ヘルスケアインフラへの投資の増加、医薬品のeコマースの拡大などにより成長が見込まれます。この期間の主な動向としては、粒子工学の進歩、先進的ネブライザーの開発、リポソーム製剤の創出、計算流体力学の進歩、スマート吸入器の革新などが挙げられます。

肺炎の罹患率の上昇が肺または呼吸器ドラッグデリバリー市場の成長を牽引すると予想されます。肺炎は肺の感染症で、気嚢に炎症が起こり、液体や膿が充満し、咳、発熱、呼吸困難などの症状が現れます。肺炎の増加要因としては、人口の高齢化、免疫力の低下、呼吸器感染症、大気汚染、喫煙、抗生物質耐性菌の増加などが挙げられます。肺または呼吸器ドラッグデリバリーは、抗生物質、気管支拡張剤、抗炎症剤などの薬剤を肺に直接投与することで肺炎の治療を支援し、症状の緩和、炎症の軽減、感染症の除去、呼吸機能の改善など、回復を助け合併症を予防するための迅速で効果的な治療を可能にします。例えば、2023年11月、熱帯医学・世界ヘルスセンターは、ケニアにおける肺炎患者の大幅な増加を報告し、2022/2023年の期間に79万3,864人に達しました。このように、肺炎の有病率の増加が肺または呼吸器ドラッグデリバリー市場の成長を牽引しています。

肺または呼吸器ドラッグデリバリー市場の企業は、治療効果と患者のコンプライアンスを向上させる複合ドラッグデリバリーシステムなどのイノベーションに注力しています。複合ドラッグデリバリーシステムは、治療薬の標的送達と制御放出を強化し、薬剤の有効性と患者の転帰を高める先進技術です。例えば、2023年7月、米国のヘルスケア企業であるViatris Inc.とドラッグデリバリーを専門とするKindeva Drug Delivery L.P.は、ブリーナ（ブデソニド・フォルモテロールフマル酸塩二水和物）吸入エアゾールを発売しました。米国食品医薬品局から承認されたこの製品は、アストラゼネカ社のシムビコートの初のジェネリック医薬品で、ブデソニドとホルモテロールを喘息や慢性閉塞性肺疾患の治療用の定量吸入器に配合したものです。強さは80マイクログラムと160マイクログラムの2種類で、ホルモテロールは4.5マイクログラムです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界肺または呼吸器ドラッグデリバリーPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の肺または呼吸器ドラッグデリバリー市場：成長率分析
• 世界の肺または呼吸器ドラッグデリバリー市場の実績：規模と成長, 2019-2024
• 世界の肺または呼吸器ドラッグデリバリー市場の予測：規模と成長, 2024-2029, 2034F
• 世界肺または呼吸器ドラッグデリバリー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の肺または呼吸器ドラッグデリバリー市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方タイプ
• デバイスタイプ
• 世界の肺または呼吸器ドラッグデリバリー市場キャニスタータイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレーンキャニスター
• コーティングキャニスター
• 世界の肺または呼吸器ドラッグデリバリー市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性閉塞性肺疾患
• 喘息
• 嚢胞性線維症
• その他の用途
• 世界の肺または呼吸器ドラッグデリバリー市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 在宅ケア設定
• 世界の肺または呼吸器ドラッグデリバリー市場、製剤タイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ドライパウダー吸入器（DPI）
• 定量噴霧式吸入器（MDI）
• ネブライザー
• 液体エアロゾル
• 鼻スプレー
• 世界の肺または呼吸器ドラッグデリバリー市場デバイスタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 吸入器（手動式およびデジタル式）
• ネブライザー（コンプレッサー式、超音波式、メッシュ式）
• 呼吸作動装置
• スペーサーデバイス
• 経鼻ドラッグデリバリーデバイス

第7章 地域別・国別分析

• 世界の肺または呼吸器ドラッグデリバリー市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の肺または呼吸器ドラッグデリバリー市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 肺または呼吸器ドラッグデリバリー市場：競合情勢
• 肺または呼吸器ドラッグデリバリー市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• 3M Company
• Koninklijke Philips N.V.
• GlaxoSmithKline
• Omron Corporation
• Teva Pharmaceutical Industries Ltd.
• Aptar Pharma
• Sumitomo Pharma America Inc.
• Chiesi Farmaceutici S.p.A.
• Cipla Inc.
• Boehringer Ingelheim GmbH
• Kindeva Drug Delivery Limited
• Nemera Group
• Hovione
• H And T Presspart Group
• Vectura Group plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 肺または呼吸器ドラッグデリバリー市場2029：新たな機会を提供する国
• 肺または呼吸器ドラッグデリバリー市場2029：新たな機会を提供するセグメント
• 肺または呼吸器ドラッグデリバリー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pulmonary or respiratory drug delivery involves the direct administration of medication into the lungs to facilitate quick absorption, targeted treatment, and minimize systemic side effects, offering both local and systemic therapeutic benefits.

The primary categories of pulmonary or respiratory drug delivery include formulation type and device type. Formulation type pertains to the method of preparing drugs for efficient delivery, ensuring precise dosing and absorption in the body. Different canister options include plain and coated canisters, which are utilized for treating conditions such as chronic obstructive pulmonary disease, asthma, cystic fibrosis, and others. These devices are commonly used across various settings, including hospitals, clinics, and home care environments.

The pulmonary or respiratory drug delivery market research report is one of a series of new reports from The Business Research Company that provides pulmonary or respiratory drug delivery market statistics, including pulmonary or respiratory drug delivery industry global market size, regional shares, competitors with a pulmonary or respiratory drug delivery market share, detailed pulmonary or respiratory drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary or respiratory drug delivery industry. This pulmonary or respiratory drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pulmonary or respiratory drug delivery market size has grown strongly in recent years. It will grow from $69.83 billion in 2024 to $76.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth during the historical period can be attributed to factors such as the increasing prevalence of asthma, greater adoption of advanced inhalation devices, a rise in global healthcare spending, growing awareness of respiratory diseases, and a higher incidence of allergic conditions.

The pulmonary or respiratory drug delivery market size is expected to see strong growth in the next few years. It will grow to $107.85 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. For the forecast period, growth is expected due to the rising demand for personalized medicine, the growing prevalence of chronic respiratory diseases, an increased focus on telemedicine, more investments in healthcare infrastructure, and the expansion of e-commerce for pharmaceutical products. Key trends during this period include advancements in particle engineering, the development of advanced nebulizers, the creation of liposomal formulations, progress in computational fluid dynamics, and the innovation of smart inhalers.

The rising incidence of pneumonia is expected to drive the growth of the pulmonary or respiratory drug delivery market. Pneumonia is a lung infection that causes inflammation in the air sacs, which may fill with fluid or pus, resulting in symptoms such as cough, fever, and difficulty breathing. Factors contributing to the increasing prevalence of pneumonia include aging populations, weakened immune systems, respiratory infections, air pollution, smoking, and the rise of antibiotic-resistant bacteria. Pulmonary or respiratory drug delivery helps treat pneumonia by directly delivering medications such as antibiotics, bronchodilators, or anti-inflammatory agents to the lungs, enabling quicker and more effective treatment to alleviate symptoms, reduce inflammation, clear infections, and improve respiratory function, thus aiding recovery and preventing complications. For example, in November 2023, the Centre for Tropical Medicine and Global Health reported a significant rise in pneumonia cases in Kenya, reaching 793,864 in the 2022/2023 period. As such, the increasing prevalence of pneumonia is driving the pulmonary or respiratory drug delivery market's growth.

Companies in the pulmonary or respiratory drug delivery market are focusing on innovations such as complex drug delivery systems that improve treatment efficacy and patient compliance. Complex drug delivery systems are advanced technologies that enhance the targeted delivery and controlled release of therapeutic agents, boosting drug effectiveness and patient outcomes. For example, in July 2023, Viatris Inc., a US-based healthcare company, and Kindeva Drug Delivery L.P., a US-based company specializing in drug delivery, launched Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol. Approved by the US Food and Drug Administration, this is the first generic version of AstraZeneca's Symbicort and combines budesonide and formoterol in a metered-dose inhaler for treating asthma and chronic obstructive pulmonary disease. It is available in two strengths, 80 micrograms and 160 micrograms, with 4.5 micrograms of formoterol.

In June 2022, Kindeva Drug Delivery acquired iPharma Labs Inc. for an undisclosed amount. This acquisition enhances Kindeva's capabilities in inhalation therapy development, allowing for improved formulation and manufacturing processes for respiratory medications. It also enables the company to offer comprehensive support to pharmaceutical clients from early-stage development to commercial production. iPharma Labs Inc. is a US-based company that specializes in pulmonary or respiratory drug delivery solutions.

Major players in the pulmonary or respiratory drug delivery market are Merck & Co. Inc., Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., GlaxoSmithKline, Omron Corporation, Teva Pharmaceutical Industries Ltd., Aptar Pharma, Sumitomo Pharma America Inc., Chiesi Farmaceutici S.p.A., Cipla Inc., Boehringer Ingelheim GmbH, Kindeva Drug Delivery Limited, Nemera Group, Hovione, H And T Presspart Group, Vectura Group plc

North America was the largest region in the pulmonary or respiratory drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pulmonary or respiratory drug delivery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pulmonary or respiratory drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pulmonary or respiratory drug delivery market consists of sales of metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, aerosol formulations, and smart inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pulmonary Or Respiratory Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pulmonary or respiratory drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pulmonary or respiratory drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pulmonary or respiratory drug delivery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Formulation Type, Device Type
• 2) By Canister Type: Plain Canister, Coated Canister
• 3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
• 4) By End-User: Hospitals, Clinics, Home Care Settings
• Subsegments:
• 1) By Formulation Type: Dry Powder Inhalers (DPIs); Metered Dose Inhalers (MDIs); Nebulizers; Liquid Aerosols; Nasal Sprays
• 2) By Device Type: Inhalers (Manual and Digital); Nebulizers (Compressor, Ultrasonic, Mesh); Breath-Activated Devices; Spacer Devices; Nasal Drug Delivery Devices
• Companies Mentioned: Merck & Co. Inc.; Novartis AG; Thermo Fisher Scientific Inc.; AstraZeneca plc; Abbott Laboratories
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pulmonary Or Respiratory Drug Delivery Market Characteristics

3. Pulmonary Or Respiratory Drug Delivery Market Trends And Strategies

4. Pulmonary Or Respiratory Drug Delivery Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Pulmonary Or Respiratory Drug Delivery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pulmonary Or Respiratory Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pulmonary Or Respiratory Drug Delivery Market Growth Rate Analysis
• 5.4. Global Pulmonary Or Respiratory Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pulmonary Or Respiratory Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pulmonary Or Respiratory Drug Delivery Total Addressable Market (TAM)

6. Pulmonary Or Respiratory Drug Delivery Market Segmentation

• 6.1. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Formulation Type
• Device Type
• 6.2. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plain Canister
• Coated Canister
• 6.3. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Obstructive Pulmonary Disease
• Asthma
• Cystic Fibrosis
• Other Applications
• 6.4. Global Pulmonary Or Respiratory Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Care Settings
• 6.5. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Formulation Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dry Powder Inhalers (DPIs)
• Metered Dose Inhalers (MDIs)
• Nebulizers
• Liquid Aerosols
• Nasal Sprays
• 6.6. Global Pulmonary Or Respiratory Drug Delivery Market, Sub-Segmentation Of Device Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inhalers (Manual and Digital)
• Nebulizers (Compressor, Ultrasonic, Mesh)
• Breath-Activated Devices
• Spacer Devices
• Nasal Drug Delivery Devices

7. Pulmonary Or Respiratory Drug Delivery Market Regional And Country Analysis

• 7.1. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pulmonary Or Respiratory Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market

• 8.1. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pulmonary Or Respiratory Drug Delivery Market

• 9.1. China Pulmonary Or Respiratory Drug Delivery Market Overview
• 9.2. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pulmonary Or Respiratory Drug Delivery Market

• 10.1. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pulmonary Or Respiratory Drug Delivery Market

• 11.1. Japan Pulmonary Or Respiratory Drug Delivery Market Overview
• 11.2. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pulmonary Or Respiratory Drug Delivery Market

• 12.1. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pulmonary Or Respiratory Drug Delivery Market

• 13.1. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pulmonary Or Respiratory Drug Delivery Market

• 14.1. South Korea Pulmonary Or Respiratory Drug Delivery Market Overview
• 14.2. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pulmonary Or Respiratory Drug Delivery Market

• 15.1. Western Europe Pulmonary Or Respiratory Drug Delivery Market Overview
• 15.2. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pulmonary Or Respiratory Drug Delivery Market

• 16.1. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pulmonary Or Respiratory Drug Delivery Market

• 17.1. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pulmonary Or Respiratory Drug Delivery Market

• 18.1. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pulmonary Or Respiratory Drug Delivery Market

• 19.1. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pulmonary Or Respiratory Drug Delivery Market

• 20.1. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market

• 21.1. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market Overview
• 21.2. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pulmonary Or Respiratory Drug Delivery Market

• 22.1. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pulmonary Or Respiratory Drug Delivery Market

• 23.1. North America Pulmonary Or Respiratory Drug Delivery Market Overview
• 23.2. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pulmonary Or Respiratory Drug Delivery Market

• 24.1. USA Pulmonary Or Respiratory Drug Delivery Market Overview
• 24.2. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pulmonary Or Respiratory Drug Delivery Market

• 25.1. Canada Pulmonary Or Respiratory Drug Delivery Market Overview
• 25.2. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pulmonary Or Respiratory Drug Delivery Market

• 26.1. South America Pulmonary Or Respiratory Drug Delivery Market Overview
• 26.2. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pulmonary Or Respiratory Drug Delivery Market

• 27.1. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pulmonary Or Respiratory Drug Delivery Market

• 28.1. Middle East Pulmonary Or Respiratory Drug Delivery Market Overview
• 28.2. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pulmonary Or Respiratory Drug Delivery Market

• 29.1. Africa Pulmonary Or Respiratory Drug Delivery Market Overview
• 29.2. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Canister Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pulmonary Or Respiratory Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape And Company Profiles

• 30.1. Pulmonary Or Respiratory Drug Delivery Market Competitive Landscape
• 30.2. Pulmonary Or Respiratory Drug Delivery Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Pulmonary Or Respiratory Drug Delivery Market Other Major And Innovative Companies

• 31.1. 3M Company
• 31.2. Koninklijke Philips N.V.
• 31.3. GlaxoSmithKline
• 31.4. Omron Corporation
• 31.5. Teva Pharmaceutical Industries Ltd.
• 31.6. Aptar Pharma
• 31.7. Sumitomo Pharma America Inc.
• 31.8. Chiesi Farmaceutici S.p.A.
• 31.9. Cipla Inc.
• 31.10. Boehringer Ingelheim GmbH
• 31.11. Kindeva Drug Delivery Limited
• 31.12. Nemera Group
• 31.13. Hovione
• 31.14. H And T Presspart Group
• 31.15. Vectura Group plc

32. Global Pulmonary Or Respiratory Drug Delivery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pulmonary Or Respiratory Drug Delivery Market

34. Recent Developments In The Pulmonary Or Respiratory Drug Delivery Market

35. Pulmonary Or Respiratory Drug Delivery Market High Potential Countries, Segments and Strategies

• 35.1 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pulmonary Or Respiratory Drug Delivery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer